openPR Logo
Press release

Anticoagulant Reversal Drugs Market Growth, Share, Trends and Overview 2023-2028

05-22-2023 11:55 AM CET | Health & Medicine

Press release from: theinsightpartners

Anticoagulant Reversal Drugs

Anticoagulant Reversal Drugs

Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00004954/?utm_source=OpenPR&utm_medium=10209

According to our new market research study on "Anticoagulant Reversal Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis - by Product, and Distribution channel," the market is expected to reach US$ 2,276.54 million in 2027 from US$ 922.55 in 2019; it is estimated to grow at a CAGR of 12.6% from 2020 to 2027. The report highlights trends prevailing in the global anticoagulant reversal drugs market, and the factors governing the market growth.

Based on distribution channel, the anticoagulant reversal drugs market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period. Hospital pharmacies offer complex and specialized medicines, which may not be available in a retail pharmacy. It ensures the availability of right medication, in the right dose and at the right time. These factors are expected to contribute to the growth of the market during the forecast period.

The global anticoagulant reversal drugs market growth is mainly attributed to the rising prevalence of atrial fibrillation (AFib) and stroke. However, the high cost of anticoagulant reversal drugs is restricting the market growth.

The report segments global anticoagulant reversal drugs market as follows:

By Product

Prothrombin Complex Concentrates

Vitamin K

Protamine

Tranexamic Acid

Idarucizumab

AndeXXa

Speak to Analyst for more details: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00004954?utm_source=OpenPR&utm_medium=10209

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Others

Company Profiles

Boehringer Ingelheim International GmbH

Pfizer Inc

Octapharma AG

Amag Pharmaceuticals, Inc

Fresenius Kabi AG

Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)

CSL Limited

China Biologic Products, Inc

Grifols, S.A

Shanghai RAAS Blood Products Co., Ltd. and Others

Rise in Prevalence of Atrial Fibrillation (AFib)

Oral anticoagulants are widely used and are highly effective in preventing thromboembolism among AFib patients. However, the use of anticoagulants may lead to bleeding in AFib patients; thus, anticoagulant reversal drugs are used to prevent bleeding.

As per the Centers for Disease Control and Prevention (CDC), in 2018, in the US, AFib was mentioned on around 175,326 death certificates and was the primary cause of death in about 25,845 of those deaths. Additionally, it has also anticipated that 12.1 million people in the US will have AFib by 2030.

Moreover, according to the European Society of Cardiology (ESC), in 2016, 7.6 million people above 65 years of age in the EU had atrial fibrillation and it is expected that the number will increase by 89% to reach 14.4 million by 2060. Similarly, as per the Stroke Association: State of the Nation 2017, more than 1 million people in the UK suffer from atrial fibrillation.

Global Anticoagulant Reversal Drugs Market 2023 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.

Directly Purchase Premium Copy of Anticoagulant Reversal Drugs Market Growth Report: https://www.theinsightpartners.com/buy/TIPRE00004954/?utm_source=OpenPR&utm_medium=10209

Contact US

Contact Person : Sameer Joshi .

Phone : +1-646-491-9876

E-mail : sales@theinsightpartners.com

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticoagulant Reversal Drugs Market Growth, Share, Trends and Overview 2023-2028 here

News-ID: 3061952 • Views:

More Releases from theinsightpartners

Antivirus Software Market Trends, Research Report, Growth, Opportunities and Forecast 2020-2030
Antivirus Software Market Trends, Research Report, Growth, Opportunities and For …
The report analyzes factors affecting Antivirus Software market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South America after evaluating political, economic, social and technological factors effecting the Antivirus Software market in these regions. Download Exclusive
Application Programming Interface Market by Shares, Industry Size, Trends, Growth Insight, By Top Players, and Forecast 2030
Application Programming Interface Market by Shares, Industry Size, Trends, Growt …
The report analyzes factors affecting Application Programming Interface market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South America after evaluating political, economic, social and technological factors effecting the Application Programming Interface market in these
Complete Guide to Asset Management System
Complete Guide to Asset Management System
Asset management is defined as any system that helps to monitor and maintain things of value to an entity or group. It is applied to both tangible asset such as buildings and intangible assets like human capital and financial asset. It is a process of developing, operating and maintaining assets lucratively. 𝗚𝗿𝗮𝗯 𝗣𝗗𝗙 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗠𝗼𝗿𝗲: - https://www.theinsightpartners.com/sample/TIPTE100000930?utm_source=OpenPR&utm_medium=10209 It helps to reduce inventory and stock management cost and utilizes existing tools
Geofencing Market Trends, Research Report, Growth, Opportunities and Forecast 20 …
The Insight Partners delivers well-researched industry-wide information on the Geofencing market. Size, Share, Growth, Industry Trends study It provides information on the market's essential aspects such as top participants, factors driving Geofencing market growth, precise estimation of the Geofencing market size, upcoming trends, changes in consumer behavioral pattern, market's competitive landscape, key market vendors, and other market features to gain an in-depth analysis of the market. Additionally, the report is

All 5 Releases


More Releases for Anticoagulant

Peptide Anticoagulant Drugs Market Massive Growth opportunity Ahead
Peptide Anticoagulant Drugs market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Peptide Anticoagulant Drugs Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply
Anticoagulant Rodenticides Market Is Expanding So Quickly
USD Analytics Market recently introduced Global Anticoagulant Rodenticides Market study with 65+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are BASF, Bayer, Syngenta, Rentokil, LiphaTech, JT Eaton, Bell Laboratories,
Anticoagulant Reversal Drugs Market In-Depth Analysis 2029
Fairfield Market Research offers a complete understanding of the Global Anticoagulant Reversal Drugs Market in its latest research report. The report includes an unbiased analysis of the market dynamics. The report covers growth prospects, market development potential, product profitability, supply and demand curves and predictions, and government policies. The report has been put together using reliable tools to assess the primary and secondary data. The data is represented in the
Anticoagulant Treatment Market 2021 | Detailed Report
The Anticoagulant Treatment market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Anticoagulant Treatment report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4988667 The Anticoagulant Treatment research report also provides
Anticoagulants Market To See Record Break Revenue $43.42 Million By 2025 | Vitam …
Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).
Anticoagulant Drugs Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anticoagulant Drugs market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/241687/global-anticoagulant-drugs-market Global Anticoagulant Drugs Market: Forecast by Type / Application / Region Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs